XPO1 and posterior cortical atrophy: Analyses of human scRNA-seq and bulk RNA-seq datasets also showed a significant increase in the expression of XPO1 in CRPC cells that also possess activated Wnt/β-catenin signaling pathways14, directly supporting the clinical relevance of aberrant activation of Wnt/β-catenin in increasing XPO1 expression during PCa progression.